Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Alzheimer's Disease

  Free Subscription

Articles published in Neurobiol Dis

Retrieve available abstracts of 86 articles:
HTML format

Single Articles

    November 2022
    Microglial ion channels: Key players in non-cell autonomous neurodegeneration.
    Neurobiol Dis. 2022;174:105861.
    PubMed     Abstract available

    October 2022
  2. LIN L, Petralia RS, Holtzclaw L, Wang YX, et al
    Alzheimer's disease/dementia-associated brain pathology in aging DPP6-KO mice.
    Neurobiol Dis. 2022 Oct 6:105887. doi: 10.1016/j.nbd.2022.105887.
    PubMed     Abstract available

  3. QUINN JF, Kelly MJ, Harris CJ, Hack W, et al
    The novel estrogen modulator STX attenuates Amyloid-beta neurotoxicity in the 5XFAD mouse model of Alzheimer's disease.
    Neurobiol Dis. 2022 Oct 6:105888. doi: 10.1016/j.nbd.2022.105888.
    PubMed     Abstract available

  4. JIN SX, Liu L, Li S, Meunier AL, et al
    Abeta oligomers from human brain impair mossy fiber LTP in CA3 of hippocampus, but activating cAMP-PKA and cGMP-PKG prevents this.
    Neurobiol Dis. 2022;172:105816.
    PubMed     Abstract available

    September 2022
  5. KATSUMATA Y, Shade LM, Hohman TJ, Schneider JA, et al
    Multiple gene variants linked to Alzheimer's-type clinical dementia via GWAS are also associated with non-Alzheimer's neuropathologic entities.
    Neurobiol Dis. 2022 Sep 30:105880. doi: 10.1016/j.nbd.2022.105880.
    PubMed     Abstract available

  6. KHANDELWAL M, Manglani K, Upadhyay P, Azad M, et al
    AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.
    Neurobiol Dis. 2022;174:105876.
    PubMed     Abstract available

  7. DE FISENNE MA, Yilmaz Z, De Decker R, Suain V, et al
    Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in mouse models.
    Neurobiol Dis. 2022 Sep 22:105875. doi: 10.1016/j.nbd.2022.105875.
    PubMed     Abstract available

  8. LI Y, Xia M, Meng S, Wu D, et al
    MicroRNA-29c-3p in dual-labeled exosome is a potential diagnostic marker of subjective cognitive decline.
    Neurobiol Dis. 2022;171:105800.
    PubMed     Abstract available

  9. YANG Z, Wang J, Chen J, Luo M, et al
    High-resolution NMR metabolomics of patients with subjective cognitive decline plus: Perturbations in the metabolism of glucose and branched-chain amino acids.
    Neurobiol Dis. 2022;171:105782.
    PubMed     Abstract available

  10. CESPEDES M, Jacobs KR, Maruff P, Rembach A, et al
    Systemic perturbations of the kynurenine pathway precede progression to dementia independently of amyloid-beta.
    Neurobiol Dis. 2022;171:105783.
    PubMed     Abstract available

  11. BLESSING EM, Parekh A, Betensky RA, Babb J, et al
    Association between lower body temperature and increased tau pathology in cognitively normal older adults.
    Neurobiol Dis. 2022;171:105748.
    PubMed     Abstract available

    August 2022
  12. GU Z, Cao H, Zuo C, Huang Y, et al
    TFEB in Alzheimer's disease: From molecular mechanisms to therapeutic implications.
    Neurobiol Dis. 2022 Aug 25:105855. doi: 10.1016/j.nbd.2022.105855.
    PubMed     Abstract available

  13. MEHTA NH, Suss RA, Dyke JP, Theise ND, et al
    Quantifying cerebrospinal fluid dynamics: A review of human neuroimaging contributions to CSF physiology and neurodegenerative disease.
    Neurobiol Dis. 2022;170:105776.
    PubMed     Abstract available

  14. WILLIAMS ET, Chen X, Otero PA, Moore DJ, et al
    Understanding the contributions of VPS35 and the retromer in neurodegenerative disease.
    Neurobiol Dis. 2022;170:105768.
    PubMed     Abstract available

    July 2022
  15. MARTINEZ-DRUDIS L, Sheta R, Pellegrinato R, Loukili S, et al
    Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease.
    Neurobiol Dis. 2022;172:105833.
    PubMed     Abstract available

  16. ZHANG Y, Gao H, Zheng W, Xu H, et al
    Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer's disease.
    Neurobiol Dis. 2022;172:105824.
    PubMed     Abstract available

  17. QIAO Y, Gast G, Su X, Saito T, et al
    Hippocampal neural circuit connectivity alterations in an Alzheimer's disease mouse model revealed by monosynaptic rabies virus tracing.
    Neurobiol Dis. 2022 Jul 14:105820. doi: 10.1016/j.nbd.2022.105820.
    PubMed     Abstract available

  18. NORAMBUENA A, Sun X, Wallrabe H, Cao R, et al
    SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-beta oligomers.
    Neurobiol Dis. 2022;169:105737.
    PubMed     Abstract available

    June 2022
  19. RAMAMOORTHY K, Yoshimura R, Al-Juburi S, Anandam KY, et al
    Alzheimer's disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation.
    Neurobiol Dis. 2022 Jun 21:105799. doi: 10.1016/j.nbd.2022.105799.
    PubMed     Abstract available

  20. JOHNSON AC, Uhlig F, Einwag Z, Cataldo N, et al
    The neuroendocrine stress response impairs hippocampal vascular function and memory in male and female rats.
    Neurobiol Dis. 2022;168:105717.
    PubMed     Abstract available

  21. AMIN J, Erskine D, Donaghy PC, Surendranathan A, et al
    Inflammation in dementia with Lewy bodies.
    Neurobiol Dis. 2022;168:105698.
    PubMed     Abstract available

  22. KORF JM, Ganesh BP, McCullough LD
    Gut dysbiosis and age-related neurological diseases in females.
    Neurobiol Dis. 2022;168:105695.
    PubMed     Abstract available

  23. AHMED MM, Wang AC, Elos M, Chial HJ, et al
    The innate immune system stimulating cytokine GM-CSF improves learning/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning/memory in wild-type mice.
    Neurobiol Dis. 2022;168:105694.
    PubMed     Abstract available

  24. TROUTWINE BR, Strope TA, Franczak E, Lysaker CR, et al
    Mitochondrial function and Abeta in Alzheimer's disease postmortem brain.
    Neurobiol Dis. 2022 Jun 3:105781. doi: 10.1016/j.nbd.2022.105781.
    PubMed     Abstract available

    May 2022
  25. ZENG Q, Li K, Luo X, Wang S, et al
    The association of enlarged perivascular space with microglia-related inflammation and Alzheimer's pathology in cognitively normal elderly.
    Neurobiol Dis. 2022 May 13:105755. doi: 10.1016/j.nbd.2022.105755.
    PubMed     Abstract available

  26. LAMPINEN R, Belaya I, Saveleva L, Liddell JR, et al
    Neuron-astrocyte transmitophagy is altered in Alzheimer's disease.
    Neurobiol Dis. 2022;170:105753.
    PubMed     Abstract available

  27. BUHL E, Kim YA, Parsons T, Zhu B, et al
    Effects of Eph/ephrin signalling and human Alzheimer's disease-associated EphA1 on Drosophila behaviour and neurophysiology.
    Neurobiol Dis. 2022 May 12:105752. doi: 10.1016/j.nbd.2022.105752.
    PubMed     Abstract available

  28. MEEKER KL, Butt OH, Gordon BA, Fagan AM, et al
    Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
    Neurobiol Dis. 2022;166:105662.
    PubMed     Abstract available

    April 2022
  29. PURIS E, Auriola S, Petralla S, Hartman R, et al
    Altered protein expression of membrane transporters in isolated cerebral microvessels and brain cortex of a rat Alzheimer's disease model.
    Neurobiol Dis. 2022 Apr 23:105741. doi: 10.1016/j.nbd.2022.105741.
    PubMed     Abstract available

  30. FILIPELLO F, Goldsbury C, You SF, Locca A, et al
    Soluble TREM2: Innocent bystander or active player in neurological diseases?
    Neurobiol Dis. 2022;165:105630.
    PubMed     Abstract available

    March 2022
  31. STRAIN JF, Barthelemy N, Horie K, Gordon BA, et al
    CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer's disease.
    Neurobiol Dis. 2022 Mar 28:105714. doi: 10.1016/j.nbd.2022.105714.
    PubMed     Abstract available

  32. KENKHUIS B, Somarakis A, Kleindouwel LRT, van Roon-Mom WMC, et al
    Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease.
    Neurobiol Dis. 2022;167:105684.
    PubMed     Abstract available

  33. MOON HJ, Haroutunian V, Zhao L
    Human apolipoprotein E isoforms are differentially sialylated and the sialic acid moiety in ApoE2 attenuates ApoE2-Abeta interaction and Abeta fibrillation.
    Neurobiol Dis. 2022;164:105631.
    PubMed     Abstract available

    February 2022
  34. GALEA E, Weinstock LD, Larramona-Arcas R, Pybus AF, et al
    Multi-transcriptomic analysis points to early organelle dysfunction in human astrocytes in Alzheimer's disease.
    Neurobiol Dis. 2022 Feb 7:105655. doi: 10.1016/j.nbd.2022.105655.
    PubMed     Abstract available

    December 2021
  35. SZABO MP, Mishra S, Knupp A, Young JE, et al
    The role of Alzheimer's disease risk genes in endolysosomal pathways.
    Neurobiol Dis. 2021;162:105576.
    PubMed     Abstract available

  36. STEPANCHUK AA, Barber PA, Lashley T, Joseph JT, et al
    Quantitative detection of grey and white matter amyloid pathology using a combination of K114 and CRANAD-3 fluorescence.
    Neurobiol Dis. 2021;161:105540.
    PubMed     Abstract available

  37. LIMORENKO G, Lashuel HA
    To target Tau pathologies, we must embrace and reconstruct their complexities.
    Neurobiol Dis. 2021;161:105536.
    PubMed     Abstract available

    November 2021
  38. LIN X, Chen L, Baglietto-Vargas D, Kamalipour P, et al
    Spatial coding defects of hippocampal neural ensemble calcium activities in the triple-transgenic Alzheimer's disease mouse model.
    Neurobiol Dis. 2021;162:105562.
    PubMed     Abstract available

  39. GONZALEZ S, McHugh TLM, Yang T, Syriani W, et al
    Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage.
    Neurobiol Dis. 2021 Nov 24:105563. doi: 10.1016/j.nbd.2021.105563.
    PubMed     Abstract available

  40. GURDON B, Kaczorowksi C
    Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models.
    Neurobiol Dis. 2021;161:105558.
    PubMed     Abstract available

  41. BIYONG ESSI F, Cyntia T, Manon L, Vicky C, et al
    Role of Retinoid X Receptors (RXRs) and dietary vitamin A in Alzheimer's disease: Evidence from clinicopathological and preclinical studies.
    Neurobiol Dis. 2021 Nov 1:105542. doi: 10.1016/j.nbd.2021.105542.
    PubMed     Abstract available

    Alternative platelet activation pathways and their role in neurodegenerative diseases.
    Neurobiol Dis. 2021;159:105512.
    PubMed     Abstract available

  43. YANGUAS-CASAS N, Torres C, Crespo-Castrillo A, Diaz-Pacheco S, et al
    High-fat diet alters stress behavior, inflammatory parameters and gut microbiota in Tg APP mice in a sex-specific manner.
    Neurobiol Dis. 2021;159:105495.
    PubMed     Abstract available

  44. LAROCCA TJ, Cavalier AN, Roberts CM, Lemieux MR, et al
    Amyloid beta acts synergistically as a pro-inflammatory cytokine.
    Neurobiol Dis. 2021;159:105493.
    PubMed     Abstract available

    October 2021
  45. MIYOSHI E, Morabito S, Swarup V
    Systems biology approaches to unravel the molecular and genetic architecture of Alzheimer's disease and related tauopathies.
    Neurobiol Dis. 2021;160:105530.
    PubMed     Abstract available

    September 2021
  46. OCHIAI T, Sano T, Nagayama T, Kubota N, et al
    Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2021 Sep 16:105510. doi: 10.1016/j.nbd.2021.105510.
    PubMed     Abstract available

  47. GRODSTEIN F, Lemos B, Yu L, Klein HU, et al
    The association of epigenetic clocks in brain tissue with brain pathologies and common aging phenotypes.
    Neurobiol Dis. 2021;157:105428.
    PubMed     Abstract available

    August 2021
  48. FITZ NF, Wang J, Kamboh MI, Koldamova R, et al
    Small nucleolar RNAs in plasma extracellular vesicles and their discriminatory power as diagnostic biomarkers of Alzheimer's disease.
    Neurobiol Dis. 2021 Aug 16:105481. doi: 10.1016/j.nbd.2021.105481.
    PubMed     Abstract available

  49. WANG X, Zhou X, Uberseder B, Lee J, et al
    Isoform-specific dysregulation of AMP-activated protein kinase signaling in a non-human primate model of Alzheimer's disease.
    Neurobiol Dis. 2021;158:105463.
    PubMed     Abstract available

  50. HE Q, Jiang L, Zhang Y, Yang H, et al
    Anti-LINGO-1 antibody ameliorates cognitive impairment, promotes adult hippocampal neurogenesis, and increases the abundance of CB1R-rich CCK-GABAergic interneurons in AD mice.
    Neurobiol Dis. 2021;156:105406.
    PubMed     Abstract available

    July 2021
  51. FUSILIER AR, Davis JA, Paul JR, Yates SD, et al
    Dysregulated clock gene expression and abnormal diurnal regulation of hippocampal inhibitory transmission and spatial memory in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2021 Jul 29:105454. doi: 10.1016/j.nbd.2021.105454.
    PubMed     Abstract available

    June 2021
  52. PAPPOLLA MA, Perry G, Fang X, Zagorski M, et al
    Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer's disease.
    Neurobiol Dis. 2021;156:105403.
    PubMed     Abstract available

    May 2021
  53. ZHANG L, Qin Z, Sharmin F, Lin W, et al
    Tyrosine phosphatase PTP1B impairs presynaptic NMDA receptor-mediated plasticity in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2021 May 24:105402. doi: 10.1016/j.nbd.2021.105402.
    PubMed     Abstract available

    April 2021
  54. MARQUEZ A, Guernsey LS, Frizzi KE, Cundiff M, et al
    Tau associated peripheral and central neurodegeneration: Identification of an early imaging marker for tauopathy.
    Neurobiol Dis. 2021;151:105273.
    PubMed     Abstract available

  55. TOZZI F, Rutigliano G, Borso M, Falcicchia C, et al
    T1AM-TAAR1 signalling protects against OGD-induced synaptic dysfunction in the entorhinal cortex.
    Neurobiol Dis. 2021;151:105271.
    PubMed     Abstract available

    March 2021
  56. JIANG N, Cupolillo D, Grosjean N, Muller E, et al
    Impaired plasticity of intrinsic excitability in the dentate gyrus alters spike transfer in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2021 Mar 22:105345. doi: 10.1016/j.nbd.2021.105345.
    PubMed     Abstract available

  57. OJO J, Eisenbaum M, Shackleton B, Lynch C, et al
    Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma.
    Neurobiol Dis. 2021;150:105237.
    PubMed     Abstract available

    February 2021
  58. TSAI AP, Lin PB, Dong C, Moutinho M, et al
    INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia.
    Neurobiol Dis. 2021 Feb 22:105303. doi: 10.1016/j.nbd.2021.105303.
    PubMed     Abstract available

  59. BASAK JM, Ferreiro A, Cohen LS, Sheehan PW, et al
    Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2021;152:105292.
    PubMed     Abstract available

  60. XUE F, Tian J, Yu C, Du H, et al
    Type I interferon response-related microglial Mef2c deregulation at the onset of Alzheimer's pathology in 5xFAD mice.
    Neurobiol Dis. 2021 Feb 1:105272. doi: 10.1016/j.nbd.2021.105272.
    PubMed     Abstract available

  61. NOORI A, Mezlini AM, Hyman BT, Serrano-Pozo A, et al
    Systematic review and meta-analysis of human transcriptomics reveals neuroinflammation, deficient energy metabolism, and proteostasis failure across neurodegeneration.
    Neurobiol Dis. 2021;149:105225.
    PubMed     Abstract available

    January 2021
  62. ALCANTARA-GONZALEZ D, Chartampila E, Criscuolo C, Scharfman HE, et al
    Early changes in synaptic and intrinsic properties of dentate gyrus granule cells in a mouse model of Alzheimer's disease neuropathology and atypical effects of the cholinergic antagonist atropine.
    Neurobiol Dis. 2021 Jan 20:105274. doi: 10.1016/j.nbd.2021.105274.
    PubMed     Abstract available

  63. KOW RL, Strovas TJ, McMillan PJ, Jacobi AM, et al
    Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.
    Neurobiol Dis. 2021;147:105148.
    PubMed     Abstract available

  64. ALCALA-VIDA R, Awada A, Boutillier AL, Merienne K, et al
    Epigenetic mechanisms underlying enhancer modulation of neuronal identity, neuronal activity and neurodegeneration.
    Neurobiol Dis. 2021;147:105155.
    PubMed     Abstract available

  65. LAMBRACHT-WASHINGTON D, Fu M, Hynan LS, Rosenberg RN, et al
    Changes in the brain transcriptome after DNA Abeta42 trimer immunization in a 3xTg-AD mouse model.
    Neurobiol Dis. 2021;148:105221.
    PubMed     Abstract available

    December 2020
  66. CALIO ML, Mosini AC, Marinho DS, Salles GN, et al
    Leptin enhances adult neurogenesis and reduces pathological features in a transgenic mouse model of Alzheimer's disease.
    Neurobiol Dis. 2020 Dec 7:105219. doi: 10.1016/j.nbd.2020.105219.
    PubMed     Abstract available

  67. PIMENOVA AA, Herbinet M, Gupta I, Machlovi SI, et al
    Alzheimer's-associated PU.1 expression levels regulate microglial inflammatory response.
    Neurobiol Dis. 2020 Dec 7:105217. doi: 10.1016/j.nbd.2020.105217.
    PubMed     Abstract available

    November 2020
  68. ANDERSEN JV, Christensen SK, Westi EW, Diaz-delCastillo M, et al
    Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2020 Nov 23:105198. doi: 10.1016/j.nbd.2020.105198.
    PubMed     Abstract available

    October 2020
  69. PENTZ R, Iulita MF, Mikutra-Cencora M, Ducatenzeiler A, et al
    A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology.
    Neurobiol Dis. 2020 Oct 29:105150. doi: 10.1016/j.nbd.2020.105150.
    PubMed     Abstract available

  70. MONTALBANO M, McAllen S, Cascio FL, Sengupta U, et al
    TDP-43 and tau oligomers in Alzheimer's disease, amyotrophic lateral sclerosis, and frontotemporal dementia.
    Neurobiol Dis. 2020 Oct 13:105130. doi: 10.1016/j.nbd.2020.105130.
    PubMed     Abstract available

  71. STEPLER KE, Mahoney ER, Kofler J, Hohman TJ, et al
    Inclusion of African American/black adults in a pilot brain proteomics study of Alzheimer's disease.
    Neurobiol Dis. 2020 Oct 10:105129. doi: 10.1016/j.nbd.2020.105129.
    PubMed     Abstract available

    June 2020
  72. PETRUSHINA I, Hovakimyan A, Harahap-Carrillo IS, Davtyan H, et al
    Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials.
    Neurobiol Dis. 2020;139:104823.
    PubMed     Abstract available

  73. DIOUF I, Bush AI, Ayton S
    Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying beta-amyloid pathology.
    Neurobiol Dis. 2020;139:104810.
    PubMed     Abstract available

  74. HSU S, Pimenova AA, Hayes K, Villa JA, et al
    Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.
    Neurobiol Dis. 2020;139:104817.
    PubMed     Abstract available

  75. BORRECA A, Valeri F, De Luca M, Ernst L, et al
    Transient upregulation of translational efficiency in prodromal and early symptomatic Tg2576 mice contributes to Abeta pathology.
    Neurobiol Dis. 2020;139:104787.
    PubMed     Abstract available

    May 2020
  76. PIMENOVA AA, Goate AM
    Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
    Neurobiol Dis. 2020;138:104785.
    PubMed     Abstract available

  77. WISNIEWSKI T, Drummond E
    APOE-amyloid interaction: Therapeutic targets.
    Neurobiol Dis. 2020;138:104784.
    PubMed     Abstract available

    April 2020
  78. MAKARAVA N, Chang JC, Molesworth K, Baskakov IV, et al
    Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.
    Neurobiol Dis. 2020;137:104783.
    PubMed     Abstract available

  79. RHEA EM, Raber J, Banks WA
    ApoE and cerebral insulin: Trafficking, receptors, and resistance.
    Neurobiol Dis. 2020;137:104755.
    PubMed     Abstract available

    March 2020
  80. FLOWERS SA, Rebeck GW
    APOE in the normal brain.
    Neurobiol Dis. 2020;136:104724.
    PubMed     Abstract available

    February 2020
  81. BITTAR A, Bhatt N, Kayed R
    Advances and considerations in AD tau-targeted immunotherapy.
    Neurobiol Dis. 2020;134:104707.
    PubMed     Abstract available

  82. AFGHAH Z, Chen X, Geiger JD
    Role of endolysosomes and inter-organellar signaling in brain disease.
    Neurobiol Dis. 2020;134:104670.
    PubMed     Abstract available

  83. SOLTI K, Kuan WL, Forizs B, Kustos G, et al
    DJ-1 can form beta-sheet structured aggregates that co-localize with pathological amyloid deposits.
    Neurobiol Dis. 2020;134:104629.
    PubMed     Abstract available

  84. WEI Z, Meng X, El Fatimy R, Sun B, et al
    Environmental enrichment prevents Abeta oligomer-induced synaptic dysfunction through mirna-132 and hdac3 signaling pathways.
    Neurobiol Dis. 2020;134:104617.
    PubMed     Abstract available

  85. HOGLUND K, Schussler N, Kvartsberg H, Smailovic U, et al
    Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration.
    Neurobiol Dis. 2020;134:104645.
    PubMed     Abstract available

    January 2020
  86. SCHWAB AD, Thurston MJ, Machhi J, Olson KE, et al
    Immunotherapy for Parkinson's disease.
    Neurobiol Dis. 2020;137:104760.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.